CONTINUUS Pharmaceuticals Secures $69.3 Million Government Contract to Manufacture Critical Medicines in the U.S. - CONTINUUS Pharmaceuticals

DoD/HHS contract will enable onshore production of three vital medicines to treat critically ill patients, including those with COVID-19. CONTINUUS will build the first GMP-certified end-to-end manufacturing facility using its proprietary technology for the production of small-molecule medicines

Click here for full press release

CONTINUUS press release Jan 21 2021

Comments are closed.